Director/PDMR Shareholding

RNS Number : 0299R
Advanced Medical Solutions Grp PLC
11 June 2018


11 June 2018

  Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

  Director/PDMR Shareholding

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 6 June 2018 that Pieter van Hoof, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 36,375 options from the Long Term Incentive Plan (LTIP). Mr van Hoof has also, following the end of the holding period, exercised 4,643 options from the Deferred Annual Bonus Plan (DAB). Mr van Hoof elected to receive an additional 58 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr van Hoof has also elected to exercise 13,608 Ordinary Shares of 5p from the Deferred Share Bonus Plan.

 

Mr van Hoof subsequently sold 61,488 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share.  As a result of these transactions Pieter van Hoof’s beneficial interest in the Company has decreased from 127,208 shares to 120,404 shares.

 

Long Term Incentive Plan (LTIP)

 

PDMR

No. of LTIPs prior to exercise

LTIPs exercised

Ordinary Shares sold

Ordinary Shares retained

LTIPs after exercise

Pieter van Hoof

108,300

36,375

36,375

Nil

71,925

 

Deferred Annual Bonus Plan (DAB)

 

PDMR

DABs prior to exercise

DABs exercised

Dividend Shares received

Ordinary Shares sold

Ordinary Shares retained

DABs after exercise

Pieter van Hoof

18,809

4,643

58

4,701

Nil

14,166

 

Deferred Share Bonus Plan (DSB)

 

PDMR

No. of DSBs prior to exercise

DSBs exercised

Ordinary Shares sold

Ordinary Shares retained

DSBs after exercise

Pieter van Hoof

28,818

13,608

13,608

Nil

15,210

 

Overall Holding

 

PDMR

Holding prior to exercise

Number of shares exercised

Dividend Shares received

Number of shares sold

Sale price (p)

Resultant holding

% of issued share capital

Pieter van Hoof

127,208

54,626

58

61,488

330.50p

120,404

0.056%

The Company further announces that it was notified on 6 June 2018 that Simon Coates, who is a Senior Manager and PDMR, elected to exercise 9,518 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 4,490 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share to cover the tax and National Insurance payable on this exercise. As a result of these transactions Simon Coates’s beneficial interest in the Company has increased from 97,581 shares to 102,609 shares.

 

Deferred Share Bonus Plan (DSB)

 

PDMR

No. of DSBs prior to exercise

DSBs exercised

Ordinary Shares sold

Ordinary Shares retained

DSBs after exercise

Simon Coates

39,736

9,518

4,490

Nil

30,218

 

Overall Holding

 

PDMR

Holding prior to exercise

Number of shares exercised

Number of shares sold

Number of shares retained

Sale price (p)

Resultant holding

% of issued share capital

Simon Coates

97,581

9,518

4,490

5,028

330.50p

102,609

0.048%

 

The Company further announces that it was notified on 8 June 2018 that Steve Bellamy, who is a Director and PDMR, transferred the legal ownership of his shares from ADM Investors Nominees Limited to HSBC Global Custody Nominee (UK) Limited. The number of shares held by Steve Bellamy and the beneficial ownership of the shares remains unchanged.

 

Overall Holding

 

PDMR

Holding prior to exercise

Number of shares sold

Sale price (p)

Resultant holding

% of issued share capital

Steve Bellamy

100,000

Nil

100,000

0.047%

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Pieter van Hoof

2.

Reason for the notification

a)

Position/status: Senior Manager/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Exercise of 36,375 shares from the Long Term Incentive Plan

· Exercise of 4,643 shares from the Deferred Annual Bonus Plan

· Award of 58 Dividend Shares from the Deferred Annual Bonus Plan

· Exercise of 13,608 shares from the Deferred Share Bonus Plan

· Sale of 61,488 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

£3.305

61,488

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 61,488

Aggregated price: £3.305

e)

Date of the transaction: 06/06/2018

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Simon Coates

2.

Reason for the notification

a)

Position/status: Senior Manager/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Exercise of 9,518 shares from the Deferred Share Bonus Plan

· Sale of 4,490 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

£3.305

4,490

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 4,490

Aggregated price: £3.305

e)

Date of the transaction: 06/06/2018

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Steve Bellamy

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Transfer of legal ownership of 100,000 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Nil

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: Nil

Aggregated price: Nil

e)

Date of the transaction: 08/06/2018

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

-End –

 

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

About Advanced Medical Solutions Group plc see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

 

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 600 employees.  For more information, please see www.admedsol.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBLGDLIGBBGIB